The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 4, 2008, Pages 286-292

  Manali, Effrosyni ^a,b   Papadopoulos, Antonios ^a,b   Tsiodras, Sotirios ^a,b   Polychronopoulos, Vlasis ^c   Giamarellou, Helen ^a,b   Kanellakopoulou, Kyriaki ^a,b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c SISMANOGLIO HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; ISONIAZID; MACROLIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; EMPIRICISM; FEMALE; FIBEROPTIC BRONCHOSCOPY; FUNGUS IDENTIFICATION; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; COMMUNITY-ACQUIRED INFECTIONS; CULTURE MEDIA; FEMALE; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM; PNEUMONIA; PNEUMONIA, BACTERIAL; SPECIMEN HANDLING; SPUTUM;

EID: 41349087525     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701663373     Document Type: Article

References (30)

1. Mandell, LA, Bartlett, JG, Dowell, SF, File Jr, TM, Musher, DM and Whitney, C. (2003) Infectious Diseases Society of America. Update of practice guidelines for the management of community acquired pneumonia in immunocompetent adults. CID, 37, pp. 1405-1433.
2. SEPAR Working group on Community Acquired Pneumonia and Tuberculosis and Respiratory Infections Assembly (2005) Guidelines for the diagnosis and treatment of community acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery. Arch Bronconeumol, 41, pp. 272-289.
3. van der Eerden, MM, Vlaspolder, F., de Graaff, CS, Groot, T., Jansen, HM and Boersma, WG. (2005) Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community acquired pneumonia. Eur J Clin Microbiol Infect Dis, 24, pp. 241-249.
4. Busk, MF, Rosenow, EC III and Wilson, WR. (1998) Invasive procedures in the diagnosis of pneumonia. Semin Respir Infect, 3, pp. 113-122.
5. Fagon, JY, Chastre, J., Domart, Y., Trouillet, JL, Pierre, J. and Darne, C. (1989) Nosocomial pneumonia in patients receiving continuous mechanical ventilation. A prospective analysis of 52 episodes with use of protected specimen brush and quantitative culture techniques. Am Rev Respir Dis, 139, pp. 877-886.
6. Rano, A., Agusti, C., Jimenez, P., Angrill, J., Benito, N. and Danes, C. (2001) Pulmonary infiltrates in non-HIV-immunocompromized patients: A diagnostic approach using non-invasive and bronchoscopic procedures. Thorax, 56, pp. 379-387.
7. Baselski, VS and Wunderink, RG. (1994) Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev, 7, pp. 533-558.
8. Ortqvist, A., Kalin, M., Lejdeborn, L. and Lundberg, B. (1990) Diagnostic fibreoptic bronchoscopy and protected brush culture in patients with community acquired pneumonia. Chest, 97, pp. 576-582.
9. Jimenez, P., Saldias, F., Meneses, M., Silva, ME, Wilson, MG and Otth, L. (1993) Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest, 103, pp. 1023-1027.
10. Rodriguez, RM, Fancher, ML, Phelps, M., Hawkins, K., Johnson, J. and Stacks, K. (2001) An emergency based randomized trial of non-bronchoscopic bronchoalveolar lavage for early pathogen identification in severe community acquired pneumonia. Ann Emerg Med, 38, pp. 357-363.
11. Ruiz, M., Ewig, S., Marcos, MA, Martinez, JA, Arancibia, F. and Mensa, J. (1999) Aetiology of community acquired pneumonia: Impact of age, comorbidity and severity. Am J Respir Crit Care Med, 160, pp. 397-405.
12. CLSI/NCCLS M100-S15 Vol.25 Performance standards for antimicrobial susceptibility testing; 15th informational supplement.
13. American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital acquired, ventilator associated and health care associated pneumonia. Am J Respir Crit Care Med, 171, pp. 388-416.
14. American Thoracic Society (1997) Diagnosis and treatment of disease caused by non-tuberculous mycobacteria. Am J Respir Crit Care Med, 156, p. S1.
15. Prats, E., Dorca, J., Pujol, M., Garcia, L., Barreiro, B. and Verdaguer, R. (2002) Effects of antibiotics on protected specimen brush sampling in ventilator associated pneumonia. Eur Respir J, 19, pp. 944-951.
16. Timsit, JF, Misset, B., Francoual, S., Goldstein, FW, Vaury, P. and Carlet, J. (1988) Comparison of non-protected lower respiratory tract secretions and protected specimen brush samples in the diagnosis of pneumonia. Intensive Care Med, 14, pp. 30-33.
17. Wimberley, NW, Bass, JB, Boyd, BW, Kirkpatrick, MB, Serio, RA and Pollock, HM. (1982) Use of bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest, 81, pp. 556-561.
18. Torres, A. and El-Ebiary, M. (2000) Bronchoscopic BAL in the diagnosis of ventilator associated pneumonia. Chest, 117, p. S198.
19. Rein, MF, Gwaltney, JM, O'Brien, WM, Jennings, RH and Mandell, GL. (1978) Accuracy of Gram stain in identifying pneumococci in sputum. JAMA, 239, pp. 2671-2673.
20. Pitsavos, C., Panagiotakos, DB, Chrysohoou, C. and Stefanadis, C. (2003) Epidemiology of cardiovascular risk factors in Greece: Aims, design and baseline characteristics of the ATTICA study. BMC Public Health, 20, p. 32.
21. Luna, CM, Famiglietti, A., Absi, R., Vileda, AJ, Nogueira, FJ and Fuenzalida, AD (2000) Community acquired pneumonia. Aetiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest, 118, pp. 1344-1354.
22. Ruiz, M., Ewig, S., Torres, A., Arancibia, F., Marco, F. and Mensa, J. (1999) Severe community acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med, 160, pp. 923-929.
23. Hadjichristodoulou, C., Vasilogiannopoulos, A., Spala, G., Mavrou, I., Kolonia, V. and Marinis, E. (2005) Mycobacterium tuberculosis transmission among high school students in Greece. Pediatr Int, 4792, pp. 180-184.
24. Arancibia, F., Bauer, TT, Ewig, S., Mensa, J., Gonzalez, J. and Niederman, MS (2002) Community acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: Incidence, risk, and prognosis. Arch Intern Med, 162, pp. 1849-1858.
25. El-Ebiary, M., Torres, A., Fabregas, N., de la Bellacasa, JP, Gonzalez, J. and Raminez, J. (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. Am J Respir Crit Care Med, 156, pp. 583-590.
26. Shefet, D., Robenshtok, E., Paul, M. and Leibovici, L. (2005) Empirical atypical coverage for inpatients with community acquired pneumonia: A systematic review of randomized controlled trials. Arch Intern Med, 165, pp. 1992-2000.
27. Menendez, R., Torres, A., Zalacain, R., Aspa, J., Martin-Villasclaras, JJ and Borderias, L. (2005) Guidelines for the treatment of community acquired pneumonia: Predictors of adherence and outcome. Am J Respir Crit Care Med, 172, pp. 757-762.
28. Aspa, J., Rajas, O., de Castro, F Rodriguez, Huertas, MC, Borderias, L. and Cabello, FJ (2006) Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J, 27, pp. 1010-1019.
29. Rosón, B., Fernández-Sabé, N., Carratalà, J., Verdaguer, R., Dorca, J. and Manresa, F. (2004) Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. CID, 38, pp. 222-226.
30. ERS Task Force Report (1998) Guidelines for management of adult community acquired lower respiratory tract infections. European Respiratory Society. Eur Respir J, 11, pp. 986-991.